CORRECTION article

Front. Endocrinol., 15 November 2024

Sec. Thyroid Endocrinology

Volume 15 - 2024 | https://doi.org/10.3389/fendo.2024.1517690

Corrigendum: Surgical outcome and malignant risk factors in patients with thyroid nodule classified as Bethesda category III

  • 1. Department of General Surgery, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China

  • 2. Shantou University Medical College, Shantou, China

  • 3. The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China

  • 4. School of Medicine, South China University of Technology, Guangzhou, China

In the published article, there was an error in the Funding statement. The Funding statement for the Guangdong Basic and Applied Basic Research Foundation was displayed as “Natural Science Foundation of Guangdong Province (No. 2020A1515010127)”. The correct statement is “Guangdong Basic and Applied Basic Research Foundation (No. 2020A1515010126)”. The correct Funding statement appears below.

“This work was supported by Guangdong Basic and Applied Basic Research Foundation (No. 2020A1515010126), Scientific Research Staring Foundation for the Returned Overseas from Guangdong Provincial People’s Hospital (No. 2017x02) and Guangdong Provincial People’s Hospital Scientific Foundation for Distinguished Young Scholars of Guangdong Province (No. KJ012019441).”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

thyroid cancer, autoimmune thyroid antibodies, tumor size, fine needle aspirate (FNA), microcalcification

Citation

Huang J, Shi H, Song M, Liang J, Zhang Z, Chen X, Liu Y, Wang S and Wu Z (2024) Corrigendum: Surgical outcome and malignant risk factors in patients with thyroid nodule classified as Bethesda category III. Front. Endocrinol. 15:1517690. doi: 10.3389/fendo.2024.1517690

Received

26 October 2024

Accepted

31 October 2024

Published

15 November 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

15 - 2024

Updates

Copyright

*Correspondence: Zeyu Wu,

†These authors have contributed equally to this work and share first authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics